• Home
  • About Us
    • Member Directory
    • Contact Us
  • Blogs
    • Scientific Blogs
      • Technology
      • Environment
      • Health
    • Infinity Explorer
    • Traveler Book
    • Life Around
  • Publication
  • Scientific Advisory
  • Project
    • Future Projects
    • Ongoing Projects
    • Previous Projects
  • Services
    • Language Programs
    • Latest Software
    • Environmental Consultancy
    • Internship
    • Exercise
  • Career
    • Masters
    • PHDs
    • Postdoctorals
    • Travel Grants
    • Others

mRNA vaccines like Pfizer and Moderna fare better against COVID-19 variants of concern

mRNA vaccines like Pfizer and Moderna fare better against COVID-19 variants of concern

COVID-19

Share:

Twitter
Tweet
LinkedIn
Share
Facebook
fb-share-icon
WeChat
Follow by Email
Hardin Bitsky

Hardin Bitsky

Mr. Hardin, a future doctor of pharmacy, provides services as a content writer for scientific and technical niches.

A comparison of four COVID-19 vaccinations shows that messenger RNA (mRNA) vaccines from Pfizer-BioNTech and Moderna perform better against the World Health Organization’s variants of concern (VOCs) than viral vector vaccines from AstraZeneca and J&J/Janssen. Although they all effectively prevent severe disease by VOCs, the research, published May 17th in the open access journal PLoS Medicine, suggests that people receiving a viral vector vaccine are more vulnerable to infection by new variants.

By March 2022, COVID-19 had caused over 450 million confirmed infections and six million reported deaths. The first vaccines approved in the US and Europe that protect against serious infection are Pfizer-BioNTech and Moderna, which deliver genetic code, known as mRNA, to the bodies’ cells, whereas Oxford/AstraZeneca and J&J/Janssen are viral vector vaccines that use a modified version of a different virus—a vector—to deliver instructions to our cells. Three vaccines are delivered as two separate injections a few weeks apart, and J&J/Janssen as a single dose.

Marit J. van Gils at the University of Amsterdam, Netherlands, and colleagues, took blood samples from 165 health care workers, three and four weeks after first and second vaccination respectively, and for J&J/Janssen at four to five and eight weeks after vaccination. Samples were collected before, and four weeks after a Pfizer-BioNTech booster.

Four weeks after the initial two doses, antibody responses to the original SARS-CoV-2 viral strain were highest in recipients of Moderna, followed closely by Pfizer-BioNTech, and were substantially lower in those who received viral vector vaccines. Tested against the VOCs—alpha, beta, gamma, delta and omicron—neutralizing antibodies were higher in the mRNA vaccine recipients compared to those who had viral vector vaccines. The ability to neutralize VOCs was reduced in all vaccine groups, with the greatest reduction against omicron. The Pfizer-BioNTech booster increased antibody responses in all groups with substantial improvement against VOCs, including omicron.

The researchers caution that their AstraZeneca group was significantly older, because of safety concerns for the vaccine in younger age groups. As immune responses tend to weaken with age, this could affect the results. This group was also smaller because the Dutch government halted use for a period.

“Four COVID-19 vaccines induce substantially different antibody responses,” concluded van Gils.

You may like to read:

The Precise Neurons That Die In Parkinson’s Disease Have Finally Been Identified

Testing a one-time treatment to relieve Parkinson’s symptoms

PrevPreviousNew robotic platform offers diagnosis and removal of lung cancer during single surgery
NextInfrared imaging to measure glymphatic functionNext

LATEST Blogs

Breakfast and health problems

Skipping Breakfast May Increase a Child’s Risk of Psychosocial Health Problems

September 7, 2022
James webb telescope

NASA’s Webb Space Telescope Captures a Cosmic Tarantula

September 7, 2022

Worse Than Smoking – Bad Sleep Can Worsen Lung Disease

August 31, 2022
Nanotechnology

Dr. Muhammad Adeel Addressed the International Con-ference as keynote speaker

August 23, 2022
Benefits of Mushrooms

Top 10 Health Benefits of Mushrooms, the Ultimate Superfood

August 18, 2022

New Way Invented To Produce Oxygen on Mars for Future Explorers

August 18, 2022

Evidence of Unprecedented Modern Sea-Level Rise Found in Ancient Caves

August 18, 2022

Research Shows Salt Substitutes Lower Risk of Heart Attack/Stroke and Death

August 13, 2022
covid symptoms

Hair Loss and Sexual Dysfunction Join Fatigue and Brain Fog in List of Long COVID Symptoms

August 13, 2022
protein

Most People Are Eating Too Much Protein – And It Has Serious Consequences

August 13, 2022

Categories

  • Scientific Blogs
  • Infinity Explorer
  • Traveler Book
  • Life Around

If you have tried to make a difference and you believe you deserve to be acknowledge, then please submit your story to us

Subscribe

Virtual Green Innovation Hub (VGI-H) is an emerging platform for young researchers which works as a bridge between You and the society.

Useful Links

Home
About us
Blogs

Subscribe Now

Don’t miss our future updates! Get Subscribed Today!

Copyright ©2022 Virtual Green Innovation Hub. All Rights Reserved.

Don’t miss our future updates. Get Subscribed Today!